About DiNovo
DiNovo is a Pharmaceuticals company, headquartered in Houston, with 51 - 200 employees and annual revenue of $5M - $20M.
DiNovo is a distributor of USP <797> <71> <800> compliance products, packaging solutions, and infusion supplies. We are designed to bring innovative products at a low cost to the healthcare market place.
Seamless Pro Tip
Use this information to figure out if this company is an ideal customer for you.
DiNovo Company Highlights
Phone Number
(800) 994-xxxx
Corporate Office Address
9067 Knight Road
Houston, 77054
Website
DiNovo Org
DiNovo has 1 C-Level, 3 VP, 2 Director, and 6 Manager employees.
DiNovo Decision Makers
- CEORaji Abboud
- CFOErik Duran
DiNovo's Tech Stack
Frequently Asked Questions About
DiNovo
Log in or sign up to get full contact details and additional support.
Who is the CEO of DiNovo?
The CEO of DiNovo is Raji Abboud. See full contact details ›
Who is the CFO of DiNovo?
The CFO of DiNovo is Erik Duran. See full contact details ›
How many senior employees does DiNovo have?
DiNovo has 12 senior employees that are typically used for decision making.
Who are the key decision makers at DiNovo?
Key decision makers at DiNovo include Raji Abboud (CEO) and Erik Duran (CFO). See full contact details ›
What technologies does DiNovo use?
DiNovo uses technologies including Cloudflare, Font Awesome, and Gravatar.
How do I contact DiNovo?
To contact DiNovo, visit dinovomed.com.
What companies are similar to DiNovo?
Companies similar to DiNovo include IA, Advanced Clinical, and Fagron.
Where is DiNovo headquartered?
DiNovo is headquartered at 9067 Knight Road, Houston.
What is the main phone number for DiNovo?
The main phone number for DiNovo is (800) 994-xxxx.
What is the official website for DiNovo?
The official website for DiNovo is dinovomed.com.
What is the annual revenue of DiNovo?
The annual revenue of DiNovo is $5M - $20M.
How many employees does DiNovo have?
DiNovo has 51 - 200 employees.
What industry is DiNovo in?
DiNovo is in the Pharmaceuticals industry.
Last updated: July 22, 2025